A Phase I Trial of SS1 (dsFv) PE38 With Paclitaxel, Carboplatin, and Bevacizumab in Subjects With Unresectable Non-Small Cell Lung Adenocarcinoma
Clinical trial NCT01051934 · COMPLETED
Trial details
- NCT number
- NCT01051934
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-29
- Primary completion
- 2011-09-28
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.